Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Robert William Padley Ahmed A Othman Alan Kivitz Heikki Mansikka Ahmed Mohamed Abdel Ghany Othman |
| Publication date | November 8, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |